Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 विचारों
• 08/09/23
0
0
एम्बेड
administrator
ग्राहकों
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
और दिखाओ
फेसबुक टिप्पणियाँ
SORT BY-
सबसे ऊपर की टिप्पणी
-
नवीनतम टिप्पणियां